Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Akinori Mochizuki"'
Publikováno v:
Artificial Life and Robotics. 26(1):149-154
This paper proposes a security testbed system for industrial control systems. In control systems, controllers are final fortresses to continue the operation of field systems. Then, we need countermeasures of controllers. The whitelisting function is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ace40728f254e750d767bb2c3908f8
http://id.nii.ac.jp/1438/00009996/
http://id.nii.ac.jp/1438/00009996/
Publikováno v:
IECON
The authors have proposed the Fallback Control System (FCS) as a countermeasure after cyber-attacks happen in Industrial Control Systems (ICSs). For increased robustness against cyber-attacks, introducing multiple countermeasures is desirable. Then,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::369ed2539c7fdcb95db5af6d26d88655
https://doi.org/10.1109/iecon.2018.8592923
https://doi.org/10.1109/iecon.2018.8592923
Publikováno v:
IECON
This paper considers a whitelisting system for programmable logic controllers (PLCs). In control systems, controllers are final fortresses to continues the operation of field devices (actuators/sensors), but they are fragile with respect to malware a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12558973473933f982a319444c1c5810
https://doi.org/10.1109/iecon.2018.8591275
https://doi.org/10.1109/iecon.2018.8591275
Publikováno v:
ASCC
Recently, defensive countermeasures of controller are important because cyber-attacks on the control system are growing highly. This paper proposes an anomaly detection method of white list using PLC (Programmable Logic Controller) as one of the coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d3715fae63f79b60cad03292c2ffaf
https://doi.org/10.1109/ascc.2017.8287441
https://doi.org/10.1109/ascc.2017.8287441
Autor:
Akinori Mochizuki, Makiko Aoyama
Publikováno v:
Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22f04343818e38dc47ff8689486f1a08
https://doi.org/10.1002/9781118274408.ch14
https://doi.org/10.1002/9781118274408.ch14
Publikováno v:
International Archives of Allergy and Immunology. 120:2-6
Background: Human umbilical vein endothelial cells (HUVEC) are an important source of hematopoietic cytokines, and interleukin-3 (IL-3)- and IL-5-induced eosinophil differentiation from CD34+ cells has been observed. To show the supportive effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765bafccaa697451e54242df7f7685d9
https://doi.org/10.1159/000053583
https://doi.org/10.1159/000053583
Publikováno v:
European Journal of Pharmacology. 343:233-237
The effects of F-1322 (N-[2-[4-(benzhydryloxy)piperidino]ethyl]-3-hydroxy-5-(3-pyridylmethoxy)-2-naphthamide) on antigen-induced eosinophil infiltration and interleukin-5 production in the airways and on in vitro eosinophil migration were investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1204042002f2f6f2f5e9805195ab4286
https://doi.org/10.1016/s0014-2999(97)01534-3
https://doi.org/10.1016/s0014-2999(97)01534-3
Publikováno v:
The Journal of allergy and clinical immunology. 112(1)
Background: Basogranulin, the novel basophil granule protein recognized by the monoclonal antibody BB1, can be released by stimulation with anti-IgE antibody or calcium ionophore. However, the kinetics and regulation of its secretion are unknown. Obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce29a301fbed8dd77b2963a5f0cab1a2
https://pubmed.ncbi.nlm.nih.gov/12847486
https://pubmed.ncbi.nlm.nih.gov/12847486
Autor:
Akinori Mochizuki, Toru Hiruma, Niro Inaba, Hisao Tomioka, Sadayoshi Onodera, Yoriko Yatabe, Norihiko Tamura, Jun Kusunoki
Publikováno v:
European journal of pharmacology. 430(1)
We investigated the effects of F-1322 (N-[2-[4-(benzhydryloxy)piperidino]ethyl]-3-hydroxy-5-(3-pyridylmethoxy)-2-naphthamide), a new compound that inhibits both thromboxane A2 synthetase and 5-lipoxygenase and that functions as a histamine antagonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd86c94cc2f00153fd537300e5c70d4
https://pubmed.ncbi.nlm.nih.gov/11698072
https://pubmed.ncbi.nlm.nih.gov/11698072
Autor:
Tetsuaki Yamaura, Bunsho Lee, Akinori Mochizuki, Kazuhiko Takasaki, Norihiko Tamura, Yasushi Higashide
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 106(1)
The pharmacological effects of N-[2-(4-(benzhydryloxy)piperidino)ethyl]-3-hydroxy-5-(3-pyridyl methoxy)-2- naphthamide (F-1322), a novel anti-asthmatic agent, was investigated in vitro. The results obtained were as follows: 1) In the isolated trachea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8971cee1ca8bf9834a007c637e84d9fd
https://pubmed.ncbi.nlm.nih.gov/7590521
https://pubmed.ncbi.nlm.nih.gov/7590521